LifeArc today announced that RQ Biotechnology Ltd (RQ Bio), a company it co-founded, has signed a licensing agreement with AstraZeneca PLC (AZN). Under the terms of the agreement, RQ Bio has granted AstraZeneca an exclusive ...
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company developing innovative cancer therapies and powerful diagnostics based on its proprietary pre|CISION™ and Affimer® platforms, is pleased to announce that AffyXell, its joint venture ...
Inflect Health, the innovation hub of Vituity, a physician-owned and operated partnership with 3500+ physicians across 350+ hospitals and 8M patients in the United States, announces the expansion of its strategic partnership with GEn1E Lifesciences, a next-generation biotech company developing ...
Popular Posts
